Skip to main content
. 2020 Dec 11;11:601594. doi: 10.3389/fendo.2020.601594

Figure 1.

Figure 1

The effect of low-carbohydrate diet (LC), sodium-glucose cotransporter 2 inhibitor (SGLT2i) and, the combination on metabolic parameters. (A) Casual blood glucose [normal-carbohydrate diet (NC) vs LC p < 0.001; NC vs NC+Ipra p < 0.005; NC vs LC+Ipra p < 0.001; LC vs NC+Ipra ns; LC vs LC+Ipra p < 0.01; NC+Ipra vs LC+Ipra <0.01]. (B) HbA1c, (C) fasting blood glucose at day 53. (D) Body weight (NC vs LC p < 0.001; NC vs NC+Ipra ns; NC vs LC+Ipra p < 0.005; LC vs NC+Ipra p < 0.001; LC vs LC+Ipra ns; NC+Ipra vs LC+Ipra < 0.01), (E) average mean daily calorie intake per mouse, (F) epididymal fat mass. (G) Urine volume per day at day 42, (H) daily glucosuria. *p < 0.05, **p < 0.01, ****p < 0.0005. (I) urinary albumin creatinine ratio (ACR). **p < 0.01, ***p < 0.001. Data are presented as means ± SEM. n=6, each group. White squares, NC; black squares, LC; white circles, NC+Ipra; black circles, LC+Ipra (A, C). White bars, NC; hatched white bars, LC; grey bars, NC+Ipra; hatched gray bars, LC+Ipra (B, D–I).